{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:58:29Z","timestamp":1780901909329,"version":"3.54.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Emerging evidence implicates the gut microbiota in the pathogenesis of adenomyosis (AM); however, whether this association is causal and through which mechanisms it operates remain largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To interrogate potential causal relationships, we performed a two-sample Mendelian randomization (MR) analysis leveraging inverse-variance weighting (IVW) as the primary estimator, complemented by MR-Egger, weighted median, and weighted mode approaches, to evaluate the causal effects of gut microbial taxa and microbiota-derived metabolic pathways on AM. We further conducted mediation analyzes to delineate the role of circulating immune-cell phenotypes in this process. In parallel, in an independent clinical cohort, 22 patients with AM and 23 age-matched healthy controls recruited from the health-screening center of our institution were enrolled according to stringent inclusion and exclusion criteria (including antibiotic-use history and long-term local residency) and subjected to shotgun metagenomic sequencing. Significant differences in the types of bacterial communities were observed between the AM group and the control group. Subsequently, the results were cross-compared with those of the MR study using the Linear Discriminant Analysis Effect Size (LEfSe) method, and further verified using the ANCOM-BC method to determine the common microbial characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MR analysis identified ten microbial taxa and ten metabolic pathways with evidence of potential causal associations with AM. Of these, nine taxa and five pathways were associated with a reduced risk of AM, including\n                      <jats:italic>Alistipes indistinctus<\/jats:italic>\n                      (OR\u00a0=\u00a00.847, 95% CI\u00a0=\u00a00.754\u20130.951,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.005,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05),\n                      <jats:italic>Ruminococcus torques<\/jats:italic>\n                      (OR\u00a0=\u00a00.818, 95% CI\u00a0=\u00a00.712\u20130.941,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.005,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), class\n                      <jats:italic>Deltaproteobacteria<\/jats:italic>\n                      (OR\u00a0=\u00a00.780, 95% CI\u00a0=\u00a00.629\u20130.967,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.024,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), family\n                      <jats:italic>Desulfovibrionaceae<\/jats:italic>\n                      (OR\u00a0=\u00a00.780, 95% CI\u00a0=\u00a00.629\u20130.967,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.024,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), order\n                      <jats:italic>Desulfovibrionales<\/jats:italic>\n                      (OR\u00a0=\u00a00.780, 95% CI\u00a0=\u00a00.629\u20130.967,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.024,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05),\n                      <jats:italic>Parasutterella excrementihominis<\/jats:italic>\n                      (OR\u00a0=\u00a00.875, 95% CI\u00a0=\u00a00.784\u20130.977,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.017,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05),\n                      <jats:italic>Ruminococcus bromii<\/jats:italic>\n                      (OR\u00a0=\u00a00.836, 95% CI\u00a0=\u00a00.718\u20130.972,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.020,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05),\n                      <jats:italic>Bacteroides finegoldii<\/jats:italic>\n                      (OR\u00a0=\u00a00.919, 95% CI\u00a0=\u00a00.855\u20130.987,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.020,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), and the genus\n                      <jats:italic>Parasutterella<\/jats:italic>\n                      (OR\u00a0=\u00a00.886, 95% CI\u00a0=\u00a00.797\u20130.986,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.026,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05); the five protective pathways comprised dTDP-L-rhamnose biosynthesis (OR\u00a0=\u00a00.819, 95% CI\u00a0=\u00a00.674\u20130.995,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.045,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), lactose and galactose degradation (OR\u00a0=\u00a00.818, 95% CI\u00a0=\u00a00.689\u20130.972,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.022,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), the reductive TCA cycle (OR\u00a0=\u00a00.919, 95% CI\u00a0=\u00a00.851\u20130.993,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.032,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), allantoin degradation to glyoxylate (OR\u00a0=\u00a00.907, 95% CI\u00a0=\u00a00.830\u20130.991,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.030,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), and glycolysis I (from glucose-6-phosphate) (OR\u00a0=\u00a00.850, 95% CI\u00a0=\u00a00.747\u20130.967,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.013,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05).\n                    <\/jats:p>\n                    <jats:p>\n                      Conversely, one taxon and five pathways were associated with an increased risk of AM: the genus\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      (OR\u00a0=\u00a01.083, 95% CI\u00a0=\u00a01.008\u20131.164,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.030,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), degradation of glucose and glucose-1-phosphate (OR\u00a0=\u00a01.202, 95% CI\u00a0=\u00a01.056\u20131.369,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.005,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), peptidoglycan biosynthesis (in Enterococcus faecium) (OR\u00a0=\u00a01.138, 95% CI\u00a0=\u00a01.007\u20131.285,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.039,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), pyruvate fermentation to acetone (OR\u00a0=\u00a01.118, 95% CI\u00a0=\u00a01.001\u20131.248,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.048,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), glycerol degradation to butanol (OR\u00a0=\u00a01.118, 95% CI\u00a0=\u00a01.011\u20131.237,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.031,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05), and\n                      <jats:italic>de novo<\/jats:italic>\n                      pyrimidine deoxyribonucleotide biosynthesis (OR\u00a0=\u00a01.216, 95% CI\u00a0=\u00a01.063\u20131.390,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.004,\n                      <jats:italic>p<\/jats:italic>\n                      ~FDR~ &amp;gt; 0.05).Mediation analysis revealed that the immune phenotype \u201cCD24 on CD24\n                      <jats:sup>+<\/jats:sup>\n                      CD27\n                      <jats:sup>+<\/jats:sup>\n                      B cells\u201d mediated the pathway from\n                      <jats:italic>Ruminococcus bromii<\/jats:italic>\n                      to AM, accounting for 32.91% of the total effect (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.020).Shotgun metagenomic profiling of the clinical cohort demonstrated no significant differences in \u03b1-diversity or \u03b2-diversity between the AM and control groups. At the phylum level, the relative abundance of Desulfobacterota was significantly decreased in the AM group (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u00a00.05), and at the genus level,\n                      <jats:italic>Alistipes<\/jats:italic>\n                      was similarly reduced (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u00a00.05). LEfSe analysis further indicated enrichment of\n                      <jats:italic>Escherichia<\/jats:italic>\n                      and\n                      <jats:italic>Clostridium<\/jats:italic>\n                      in the AM group, whereas\n                      <jats:italic>Desulfobacterota<\/jats:italic>\n                      and\n                      <jats:italic>Rikenellaceae<\/jats:italic>\n                      were enriched in the Control group. Matching the aforementioned results with the Mendelian randomization (MR) outcomes revealed that\n                      <jats:italic>Desulfovibrionales<\/jats:italic>\n                      and\n                      <jats:italic>Desulfovibrionaceae<\/jats:italic>\n                      constituted the shared microbial taxa. This finding was subsequently re-validated and confirmed using the ANCOM-BC method.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Integrating genetic causal inference with clinical metagenomic validation, this study provides convergent evidence that specific gut microbial taxa, their associated metabolic pathways, and immune-cell\u2013mediated mechanisms may be causally implicated in the development of AM. These findings offer a framework for future microbiota-targeted preventive and therapeutic strategies against AM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1772864","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:11:20Z","timestamp":1780899080000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between gut microbiota and adenomyosis: metagenomics sequencing and Mendelian randomization"],"prefix":"10.3389","volume":"16","author":[{"given":"Chunxi","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Gynecology, Shenzhen Baoan Women\u2019s and Children\u2019s Hospital","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Guizhou Maotai Hospital","place":["Zunyi, China"]},{"name":"Zunyi Medical University and Science and Technology College","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Guizhou Maotai Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Guizhou Maotai Hospital","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaokun","family":"She","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First People\u2019s Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University","place":["Zunyi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41587-020-0603-3","article-title":"A unified catalog of 204,938 reference genomes from the human gut microbiome","volume":"39","author":"Almeida","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/humupd\/dmaa038","article-title":"Immunological changes associated with adenomyosis: a systematic review","volume":"27","author":"Bourdon","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"B3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2307\/1942268","article-title":"An ordination of the upland forest communities of southern Wisconsin. Ecological monographs 27","volume":"27","author":"Bray","year":"1957","journal-title":"Ecol. Monogr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.fertnstert.2023.03.006","article-title":"Endometriosis and adenomyosis: shared pathophysiology","volume":"119","author":"Bulun","year":"2023","journal-title":"Fertil. Steril"},{"key":"B5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat. Methods Med. Res."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ismejo\/wraf185","article-title":"Liberation of galactose from lactose by gut microbial \u03b2-galactosidase prevents uterine bacterial infection","author":"Cai","year":"2025","journal-title":"ISME J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"Carter","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12033","article-title":"Desulfovibrio is not always associated with adverse health effects in the Guangdong Gut Microbiome Project","volume":"9","author":"Chen","year":"2021","journal-title":"PeerJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1075387","article-title":"An insight into gut microbiota and metabolites in the mice with adenomyosis","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104947","article-title":"Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease","volume":"159","author":"Couto","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jogc.2023.04.008","article-title":"Guideline no. 437: diagnosis and management of adenomyosis","volume":"45","author":"Dason","year":"2023","journal-title":"J. Obstetrics Gynaecol. Canada: JOGC = J. d'Obstetrique Gynecologie du Canada: JOGC"},{"key":"B13","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","article-title":"Environmental factors shaping the gut microbiome in a Dutch population","volume":"604","author":"Gacesa","year":"2022","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1163\/18762891-bja00047","article-title":"Multifactorial effects of probiotic Parasutterella excrementihominis on gestational inflammation, offspring behaviour and prenatal-stress induced disruptions in tryptophan metabolism","volume":"16","author":"Galley","year":"2024","journal-title":"Benef Microbes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/REP-22-0224","article-title":"Cracking the enigma of adenomyosis: an update on its pathogenesis and pathophysiology","volume":"164","author":"Guo","year":"2022","journal-title":"Reproduction"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030842","article-title":"The role of platelets in the pathogenesis and pathophysiology of adenomyosis","volume":"12","author":"Guo","year":"2023","journal-title":"J. Clin. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9956259","DOI":"10.1155\/mi\/9956259","article-title":"Immunocytes Mediate the Effects of Gut Microbiome on Inflammatory Bowel Disease: Insights From a Mendelian Randomization Study","volume":"2025","author":"He","year":"2025","journal-title":"Mediators Inflamm."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04603-8","article-title":"Potential roles of the interactions between gut microbiota and metabolites in LPS-induced intrauterine inflammation (IUI) and associated preterm birth (PTB)","volume":"22","author":"Jia","year":"2024","journal-title":"J. Transl. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1001\/jama.2020.26436","article-title":"Diagnosis, evaluation, and treatment of adenomyosis","volume":"326","author":"Kho","year":"2021","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1342313","article-title":"Investigating the causal association between gut microbiota and type 2 diabetes: a meta-analysis and Mendelian randomization","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-021-00992-y","article-title":"Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project","volume":"54","author":"Lopera-Maya","year":"2022","journal-title":"Nat. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2019.1613124","article-title":"Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components","volume":"11","author":"Lordan","year":"2020","journal-title":"Gut Microbes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1142140","article-title":"Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study","volume":"13","author":"Luo","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1103\/PhysRevA.72.052310","article-title":"Jensen-Shannon divergence as a measure of distinguishability between mixed quantum states","volume":"72","author":"Majtey","year":"2005","journal-title":"Phys. Rev. A."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196130","article-title":"The present and the future of medical therapies for adenomyosis: a narrative review","volume":"12","author":"Moawad","year":"2023","journal-title":"J. Clin. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat. Genet."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1042189","article-title":"Gut microbiome and human health: exploring how the probiotic genus Lactobacillus modulate immune responses","volume":"13","author":"Rastogi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B29","first-page":"2291","article-title":"CD24 is expressed on FoxP3+ regulatory T cells and regulates their function","volume":"14","author":"Shi","year":"2022","journal-title":"Am. J. Trans. Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.631552","article-title":"The role of gut microbial \u03b2-glucuronidase in estrogen reactivation and breast cancer","volume":"9","author":"Sui","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1110001","article-title":"Female reproductive tract-organ axes","volume":"14","author":"Takada","year":"2023","journal-title":"Front. Immunol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1363080","article-title":"Unraveling the relationship between gut mic robiota and site-specific endometriosis: a Mendelian randomization analysis","volume":"15","author":"Tang","year":"2024","journal-title":"Front. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/s-0040-1718920","article-title":"Epidemiology of adenomyosis","volume":"38","author":"Upson","year":"2020","journal-title":"Semin. Reprod. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/aogs.14847","article-title":"Comparative analysis of endometrial, vaginal, and gut microbiota in patients with and without adenomyosis","volume":"103","author":"Vald\u00e9s-Bango","year":"2024","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1320992","article-title":"Causal effects of gut microbiota on appendicitis: a two-sample Mendelian randomization study","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"18971","DOI":"10.1021\/acs.jafc.4c04193","article-title":"Different short-chain fatty acids unequally modulate intestinal homeostasis and reverse obesity-related symptoms in lead-exposed high-fat diet mice","volume":"72","author":"Wang","year":"2024","journal-title":"J. Agric. Food. Chem."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1305361","article-title":"Causal association between gut microbiota and fibromyalgia: a Mendelian randomization study","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2307\/1948435","article-title":"Vegetation of the Siskiyou mountains, Oregon and California","volume":"30","author":"Whittaker","year":"1960","journal-title":"Ecol. Monogr."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151033","article-title":"Administration of Alistipes indistinctus prevented the progression from nonalcoholic fatty liver disease to nonalcoholic steatohepatitis by enhancing the gut barrier and increasing Lactobacillus spp","volume":"741","author":"Xu","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"94.e1","DOI":"10.1016\/j.ajog.2020.01.016","article-title":"Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015","volume":"223","author":"Yu","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12071476","article-title":"Gut microbiota composition is causally linked to multiple sclerosis: a Mendelian randomization analysis","volume":"12","author":"Zancan","year":"2024","journal-title":"Microorganisms"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01058-15","article-title":"Unique organization of extracellular amylases into amylosomes in the resistant starch-utilizing human colonic Firmicutes bacterium Ruminococcus bromii","volume":"6","author":"Ze","year":"2015","journal-title":"mBio"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13316","article-title":"Dietary fiber-derived short-chain fatty acids: a potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease","volume":"22","author":"Zhang","year":"2021","journal-title":"Obes. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"28301","DOI":"10.1038\/s41598-024-79227-z","article-title":"Bidirectional Mendelian randomization links gut microbiota to primary biliary cholangitis","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1772864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:11:23Z","timestamp":1780899083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1772864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2026.1772864"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1772864","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1772864"}}